The results were validated with The Cancer Genome Atlas (TCGA) dataset with 489 cases, which showed a significant decrease of CYGB expression in breast cancer that includes both invasive ductal breast carcinomas (IDBC) and invasive lobular breast carcinomas (ILBC) (Additional file 2: Figure S1A). This evidence concerns the gene CYGB and invasive lobular breast carcinoma.